Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
https://www.investormeetcompany.com/canadian-overseas-petroleum-limited/register-investor
Could be interesting, it's got to come from somewhere. Perhaps we can be of assistance?
https://www.reuters.com/world/uk/britain-increase-tariffs-russian-platinum-palladium-new-sanctions-2022-05-08/
www.signalshares.com or via your own share dealing platform... ii or HL or whomever you use.
Thanks SeisNav
Does anyone have access to the agenda for the last AGM? I can't find it anywhere so, I can't track down the wording for the withdrawn resolution (6)...
From the results of the AGM:
Jubilee's Annual General Meeting was held at 11 a.m. today (1 p.m. South African time), Wednesday, 29 December 2021. Resolution 6 was withdrawn and resolutions 1 to 5 and resolution 7 proposed at the meeting were passed with the requisite majority votes.
Just wondering if this is another EGM is another attempt to get through whatever was withdrawn at the AGM.
FT says...
Shares outstanding 194.52m
Free float 179.64m
as of Jan 17 2022 08:27 GMT.
'CEO, Gerry Brandon will provide a live presentation relating to Project Updates - @Labskin @skintrustclub
@Modern_Water - on 31st Mar 2021 at 1:30pm BST Investors can sign up for free here
https://investormeetcompany.com/deepverge-plc/register-investor'
which ties in nicely with : MSYS) the micro-engineering, miniaturised chip-based mass spectrometry producer for point-of-need analytical detection, announces that it has signed a non-binding Heads of Terms with DeepVerge plc (AIM: DVRG) ("DeepVerge") to enter a multi-year Framework Services Agreement ("Agreement"). Under the Agreement, which is expected to be signed on or before 31 March 2021
https://www.investegate.co.uk/microsaic-systems--msys-/rns/framework-services-agreement/202102150700070250P/
haggismchaggis1
Got part 1
Is there a part 2? As you say you couldn't post it all in one go.
Thanks
41M make that...
+ another 41 +40+40 M
Saudi Surprise Cut Continues To Lift Oil Prices
https://oilprice.com/Latest-Energy-News/World-News/Saudi-Surprise-Cut-Continues-To-Lift-Oil-Prices.html
RNS Number : 2915I
Deepverge PLC
11 December 2020
11 December 2020
DeepVerge PLC
("DeepVerge" or "the Company")
New Labskin service 'soft launched' in August already nets £400,000 in completed orders in Q4
Service has attracted new household name clients
DeepVerge (LSE:DVRG.L), the environmental and life science AI company, is pleased to announce a new R&D service, launched in August 2020, has already generated £400,000 in completed sales in Q4 with agreements with 10 new clients that had previously not used Labskin services. These agreements include framework Master Services Agreements with 2 of the world's largest suppliers of consumer products related to skincare.
The new service, designed to quickly validate the impact of ingredients such as probiotics and prebiotics on the skin microbiome, clones the human skin microbiome using six microbial strains and delivers real world environment results that mirror the impact of treatments and therapeutics on real human skin.
The new R&D service adds to the existing client offering. It increases revenue per client and delivers higher value test services on ingredients used in an expansive range of products - from anti-viral, to shampoos to babies' nappies. The new service replicates skin conditions of the scalp, face, mouth and abdomen. It also utilises AI which has significantly improved the speed and accuracy of testing ingredients on virtual skin models.
Gerard Brandon, CEO of DeepVerge, Commented:
"When we designed this new service we built on three key platforms : Labskin's ability to grow human skin, its expertise in replicating the skin's microbial environment from different parts of the body and its increasing use of AI and data which helps with speed, accuracy and insights. While we will fully launch the product at conferences across all regions in 2021, it has already resulted in significant interest and orders from existing and new clients as well as from new clients in new sectors/markets.
The Labskin division has become a recognised global leader in cloning and testing real-world human skin microbiome in a laboratory with a rapidly expanding order book from a growing blue chip client base. Since September 2019, the team has increased revenue per client exponentially by offering multiple value-added solutions beyond its core laboratory testing services which lower client development costs of product information validation enabling new products get to market faster."
For further information please contact:
DeepVerge plc
Gerard Brandon, CEO
+44 (0) 7340 055 648
SPARK Advisory Partners Limited
(Nominated Adviser)
Neil Baldwin/Andrew Emmott
+44 (0) 113 370 8974
Turner Pope Investments (TPI) Limited (Broker)
Andy Thacker/Zoe Alexander
+44 (0) 20 3657 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is a scienti
DVRG Share Chat is up and running on LSE
F.Y.I.
Ahead of the In-Cosmetics Virtual Conference [i] for ingredient suppliers today, the Company announces that Labskin has received initial orders worth c£190,000 to be completed this quarter, with four new customers, each a global player, with combined sales revenues of US$56 Billion in the cosmetics, personal care, and medical device sectors. This adds to the existing growing business of Labskin and further underpins the guided revenue of £4m for 2020.
From:
Deepverge PLC
Name, ticker change effective; 4 new contracts
RNS Number : 2151B
Deepverge PLC
06 October 2020
DeepVerge plc (formerly known as Integumen)
Change of Name effective; ticker update
Four new Labskin contracts with global companies
6 October 2020: DeepVerge plc ("DeepVerge" or "the Company") today announces the change of name from Integumen plc to DeepVerge plc which has now been officially confirmed by the Registrar of Companies. The Ordinary Shares will trade under the name DeepVerge plc (with ticker DVRG) from 8:00 a.m. today.
The Company's website is now www.deepverge.com , although the www.integumen.com website will remain in operation and will redirect to the new site. All information required by AIM Rule 26 is located on the new site.
Ahead of the In-Cosmetics Virtual Conference [i] for ingredient suppliers today, the Company announces that Labskin has received initial orders worth c£190,000 to be completed this quarter, with four new customers, each a global player, with combined sales revenues of US$56 Billion in the cosmetics, personal care, and medical device sectors. This adds to the existing growing business of Labskin and further underpins the guided revenue of £4m for 2020.
Gerry Brandon, CEO, commented:
"The Company has changed dramatically since I joined as CEO a little over two years ago and we have not only driven the core Labskin business, now recognised as a thought leader and product development partner in the skincare world, but we have also ventured into new and important fields, with artificial intelligence services in wastewater equipment and real-time breathalyser COVID-19 products.
"DeepVerge reflects who we have become. A company based on Deep science in diagnostics and environmental contamination detection on the Verge of applied engineering innovation on land, sea and air. Our new name and visual identity are a signal that we are entering a new era for the Company - strong, bold and driven - connecting our core pillars of science, technology, environment and health to tackle the challenges of the future."
Enquires:
26 August 2020
Integumen PLC
("Integumen" or "Company")
Exercise of Warrants
Integumen announces that it has received notification from multiple warrant holders to exercise warrants over 1,928,573 shares in the share capital of Integumen ("the Warrant Shares") at an exercise price of 2 pence. T he consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £38,571.46.
Total voting rights
The Warrant Shares were allotted on 26 August 2020. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 2 September 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.
The Company's total issued share capital, following the issue of the Warrant Shares, will be 1,113,049,283 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.
Integumen plc
Gerard Brandon, CEO
5 August 2020
COLUMBUS ENERGY RESOURCES PLC
("Columbus" or the "Company")
Corporate Update - Court Sanction of Merger with Bahamas Petroleum Company plc
Columbus, the oil and gas producer and explorer focused on onshore Trinidad and Suriname, is pleased to announce that the Scheme, to effect the merger with Bahamas Petroleum Company plc ("BPC"), was sanctioned by the Court earlier today ("Court Sanction"). The Scheme will become effective upon the Court Order being delivered to the Registrar of Companies, which is expected to take place on or about 7 August 2020, consistent with the expected timetable of events as set out in the Scheme Document.
Dealings in Columbus Shares will be suspended with effect from 7.30 a.m. on 7 August 2020. Accordingly, 6 August 2020 will be the last day of dealings in, and registration of transfers of, Columbus Shares.
Subject to the Scheme becoming effective, it is expected that the admission to trading of Columbus Shares on AIM will be cancelled at 7.00 a.m. on 10 August 2020. A further announcement will be made by BPC when the Scheme has become effective. ...
From RNS 05 Aug 2020 4:45 pm
Has anyone else received information on an E.G.M. being held on the 20th Feb? I can't see any RNS on the subject but I have received a voting prompt from Interactive Investor... 2020? ?EXTRAORDINARY GENERAL MEETING?
Vote by ?17-FEB-2020?
What have I missed?
Done. It turned out to be relatively easy on /via my ii account.